Global Raynauds Disease Market, By Drug Class (Beta-Blockers, Prolactin inhibitors, Calcineurin inhibitors, Antibiotics / Antineoplastics, Antimigraine agents, Antirheumatics, Antianginal agents, Vasodilators), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Store, E-Commerce) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

The regions that make up the global market for Raynaud's disease are Latin America, North America, Europe, Asia Pacific, the Middle East, and Africa. North America dominates the global market for managing Raynaud's phenomenon due to its reimbursement environment and skilled practitioners. Europe is anticipated to rank second in the market due to the availability of disposable cash and better healthcare facilities. Better health scenarios and facilities are driving Raynaud's phenomenon management market in the Asia Pacific and the Middle East.